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Abstract
Microdeletion 15q24 is an emerging syndrome recently described, mainly due to increased use of array-CGH. Clinical features
associate mild to moderate developmental delay, typical facial characteristics (high forehead and frontal hairline, broad eyebrows,
down-slanting palpebral features, long philtrum), hands (particularly proximal implanted thumbs) and genital anomalies
(micropenis, hypospadias).
We report here four cases having 2.5 6.1 Mb deletions involving 15q24: one 15q23q24.2 (patient 1) and three 15q24.1q24.2de novo –
deletions (patients 2, 3 and 4). We correlate phenotype to genotype according to molecular boundaries of these deletions. Since
bilateral iris coloboma and severe ano-rectal malformation were only present in patient 1, we could link these anomalies to
haploinsufficiency of 15q23 genes. Neither hypospadias nor micropenis were present in patient 3 bearing the smallest deletion,
therefore we could define 500 kb 15q24.1 region linked to these anomalies.
MESH Keywords Child ; Child, Preschool ; Chromosome Breakage ; Chromosome Deletion ; Chromosomes, Human, Pair 15 ; genetics ; Comparative Genomic
Hybridization ; Female ; Genotype ; Humans ; Infant ; Infant, Newborn ; Male ; Phenotype ; Pregnancy
Author Keywords 15q24 deletion ; genotype-phenotype correlation ; array-CGH
Introduction
Microdeletion of 15q24 is a recent emerging syndrome mainly identified due to widespread use of array-CGH widespread use.
Although there is an important phenotypic variability, patients may share some common findings, and these deletions could potentially
represent a clinically identifiable syndrome ( ). Clinical features therefore associate mild to moderate developmentalSharp and others 2007 
delay, distinctive facial characteristics (high forehead and frontal hairline, broad eyebrows, down-slanting palpebral features, long
philtrum), hand anomalies (particularly proximal placement of thumbs), and genital malformations in males (micropenis, hypospadias) (
; ) ( ).Cushman and others 2005 Sharp and others 2007 Klopocki and others 2008 
We report detailed studies of four patients with 15q24 deletions, having common features and compare these findings with 9
previously reported cases in the literature ( ; ; ; Cushman and others 2005 Klopocki and others 2008 Masurel-Paulet and others 2009 Sharp
; ).and others 2007 Van Esch and others 2009 
Patients and Methods
is the first child of healthy non consanguineous parents, born after a previous early miscarriage. During pregnancy, intraPatient 1 
uterine growth retardation (IUGR) was diagnosed at 26 weeks  gestation (WG). Later on, ventricular septal defect was identified on the’
third trimester ultrasound, together with single umbilical artery. Chromosome analysis and 22q11.2 FISH performed on amniotic fluid
were normal. He was born at 35 WG by caesarean section performed for maternal preeclampsia, with a birth weight of 1.900 kg (10 25– th 
centile), a length of 43 cm (10 25 centile), and a head circumference of 30 cm (10 25 centile). At birth, several malformations were– th – th 
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identified including an imperforate anus, a bilateral iris coloboma, bilateral single palmar creases, bilateral II III toe syndactyly,–
hypoplastic 5 toes with absent 5 toe nails, and a micropenis with a coronal hypospadias and a left cryptorchidism. The cardiacth th 
malformation was confirmed. He was first referred to the genetic clinic at 4 months, having severe hypotonia and post natal growth
retardation with a weight of -4SD, a height of -3DS and a HC of -3SD. Striking dysmorphic features were identified comprising of
dysplastic asymmetric ears, large and high forehead, hypoplastic nasal bridge, small nose with anteverted nares, up-slanting palpebral
fissures, bilateral epicanthus and a high palate ( ). His skin appeared very dry. Later on, he underwent surgery for left inguinalFig. 1a 
hernia where nystagmus was noted.
Developmental delay occurred secondarily. Head control was acquired at 19 months. At 2 years, he was sitting by himself and his
growth parameters were in the normal range with height -1SD, weight -1SD and HC -1SD. Unfortunately, he died at home by the age of
25 months due to unknown cause. Parents declined post-mortem examination. Several investigations were performed that includes, high
resolution chromosome banding which was normal, along with renal scan, skeletal x-rays, electromyogram and nerve conduction
velocities. Visual evoked potentials and 7-dehydrocholesterol were also normal except brain MRI that revealed cerebral atrophy and
enlarged ventricles.
is the third child of healthy non consanguineous parents. He was born after a normal pregnancy, at 38 WG with normalPatient 2 
growth parameters (weight 3.170 kg, height 53 cm and HC 33 cm). Hypospadias was noted at birth in association with hypotonia and short
proximal implanted thumbs. Dysmorphic features comprising of high and large forehead with small mouth were observed ( ).Fig. 1b 
Developmental delay occurred later on, and walking independantly was achieved at 29 months. When referred to the genetic clinic at 3
years, growth parameters were normal. However, joint laxity was noted, but thumbs and facial features were still abnormal. High
resolution chromosome banding was normal, along with renal and heart ultrasounds. However, skeletal x-rays revealed bilateral short first
metacarpals, eye examination identified bilateral papilloedema and thick corpus callosum was noted on brain MRI.
is the second child born to healthy non consanguineous parents. During pregnancy, Fallot tetralogy was suspected andPatient 3 
chromosomes including 22q11.2 by FISH analysis were observed to be normal on aminotic fluid. He was born at 39 WG, with normal
growth parameters (weight 3.450 kg, height 49.5 cm and HC 35 cm). At birth, the cardiac anomaly was confirmed and he underwent
several surgical interventions. Developmental delay was secondarily noted with head control achieved at 9 months, sitting at 15 months
and walking at 3 years. Speech was also delayed (first words at 3 years). When referred to the genetic clinic at the age of 3 years,
dysmorphic features were noted with asymmetric dysplastic ears, thin upper lip and widely-spaced teeth ( ). His skin was dry. EyeFig. 1c 
examination revealed strabismus and hypermetropia. A bilateral sensorineural deafness was identified. High resolution chromosome
banding was normal. Brain MRI revealed hypoplastic olfactory bulbs. Semi-circular canals were normal. molecular analysis wasCHD7 
normal that ruled out CHARGE syndrome.
is the first child of healthy non consanguineous parents. During pregnancy, intra uterine growth retardation was noted. ShePatient 4 
was born at 37 WG with a weight of 1.850 kg, height of 45.5 cm and HC of 31 cm. At birth, dysmorphic facial features were noted with
large and high forehead, flat midface, thin lips, small mouth and posteriorly rotated ears. Developmental delay was noted, with sitting at 11
months, walking at 2  years and first words at 3 years. When reviewed in the genetic clinic at the age of 7 years, growth parameters were½
normal. Dysmorphic features were still present ( ) with adducted thumbs and genu valgum. Eye examination revealedFig. 1d 
hypermetropia. High resolution chromosome banding was normal together with metabolic investigations, brain MRI and molecular
analyses that ruled out Prader-Willi syndrome and Steinert disease.
Array-CGH analysis
Genomic DNA was extracted from the four patients  peripheral blood lymphocytes using the QIAamp DNA Blood Midi kit (Qiagen,’
Valencia, CA) according to the manufacturer s instructions. DNA concentration was determined with NanoDrop ND-1000’
spectrophotometer and software (NanoDrop Technologies, Berlin, Germany). Detection of gene copy number was performed by
array-Comparative Genomic Hybridization (array-CGH) experiments following standard and manufacturer s recommendations using’
44.000 oligo probes approximately spaced at 40 100 kb intervals across the genome (Human Genome CGH microarray 44B kit, Agilent–  ™
). Male or female genomic DNA (Promega ) was used as reference in sex-match hybridizations which were analyzed with the ™
CGH-analytics software v3.4 by applying Z-score segmentation algorithm with a window size of 10 points to identify chromosome
aberrations. Analysis was performed with filter settings: 3-point filter and 0.2 of variation.
BACs and PACs DNAs were extracted by Macherey-Nagel kit (Nucleobond, 74579, Hoerdt, France) and labelled with Cy3-dUTP
(Amersham Bioscience, PA53022, GEhealthcare, Europe Gmbh, Munich, Germany) by nick-translation (Nick Translation System,
18160-010, Invitrogen, San Diego, CA, USA). The Cy3-labelled DNA probe was precipitated and hybridized using standard procedures.
Twenty metaphases were analyzed under fluorescence DMRB microscope (Leica) equipped with Metasystem Isis software (Altlussheim,
Germany). The following academic BAC clone probes were used: on chromosome 15: RP11-375D9 (67.2 Mb), RP11-64K10 (68.7 Mb),
RP11-141J4 (72.8 Mb), RP11-78M2 (74.5 Mb) (Sanger institute, UK).
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Results
Array-CGH 44K Agilent showed 2.5 6.1 Mb deletions involving 15q24 ( ): one 15q23q24.2 (patient 1) and three ™ – Fig. 2 
15q24.1q24.2 deletions ( ).Table I 
FISH studies confirmed the 15q23q24.2 aberration elicited by array-CGH, since the RP11-64K10 and RP11-141J4 clones were
deleted. The deletion was absent on parental DNA and appeared to be in patient 1: 46, XY, ish del(15)(q23q24.2)(RP11-375D9 ,de novo +
RP11-64K10-, RP11-141J4-, RP11-78M2 ) 25 . For the deleted 15q24.1q24.2 in patients 2, 3 and 4: RP11-141J4 clone was deleted+ [ ]dn 
and absence of deletion in the parents confirmed origin.de novo 
Discussion
There are several reports of 15q deletions involving q24. However, to the best of our knowledge, only 7 published cases have been
identified by array-CGH ( ; ; ; Klopocki and others 2008 Masurel-Paulet and others 2009 Sharp and others 2007 Van Esch and others 2009 
). Taking together with our results we could define a 1.1 Mb region on 15q24.1q24.2 in which 23 genes are located. Among them, several
are interesting in delineating the 15q24 deletion phenotype ( ).table 2 
Patient 1 is bearing the largest deletion and showed the most severe phenotype. Additional clinical characteristics may thus be
correlated to the 3Mb additional 15q23 deletion between 67.8 and 70.8 Mb.
Some of the common facial characteristics previously described in 15q24 deletion syndrome were observed in our patients, mainly
high forehead (3/4) and dysplastic ears (3/4) ( ; ; ; Cushman and others 2005 Klopocki and others 2008 Masurel-Paulet and others 2009 
). Musculo-skeletal anomalies such as limb anomalies, joint laxity and scoliosis have also been frequentlyVan Esch and others 2009 
observed in 15q24 deleted patients. Malformations of the extremities were present in 3/4 patients with proximal implanted thumbs in
patients 2 and 4 and bilateral single palmar creases and II III toe syndactyly in patient 1.–
Genital abnormalities in males are frequent in 15q24 deletion ( ). Hypospadias was present in two of theKlopocki and others 2008 
male patients (1 and 2) and absent in patient 3 bearing the smallest deletion. Thus we hypothesized that genital anomalies may be linked to
the 15q24.2 genes deleted in patients 1 and 2 but not in patient 3, i.e. between chr15:73,316,640 and chr15:73,807,021 bp. Ten genes are
located within these 490 kb and among them and are significantly expressed in human testis and may potentially beSIN3A ODF3L1 
involved. is strongly expressed in adrenal gland and haploinsufficiency of this gene may also contribute to the genitalCYP11A1 
abnormalities seen in 15q24 deleted patients ( ). Although is not deleted in patient 3, its strongKlopocki and others 2008 CCDC33 
expression in testis could be linked with genital anomalies in patients 1 and 2. Absence of genital anomalies in patient 3 may therefore be
explained by incomplete penetrance, variable expressivity or other genes involvement.
Since eye abnormalities have been previously reported in the literature and also identified in our patients, we focused our attention on 
which is involved in syndromic autosomal recessive microphthalmia type 9 (MCOPS9). Bilateral iris coloboma was present inSTRA6 
patient 1. Ophthalmologic examination of two patients with 15q22q25 and 15q21q24 deletions who died at the age of 2 years with
respiratory problems showed hypopigmentation and coloboma of the iris in one of them ( ). Among the 15q23Formiga and others 1988 
genes deleted in patient 1, is expressed in the eye anterior segment ( ) as well as (UACA Ohkura and others 2004 PARP6 Hassa and
).Hottiger 2008 
Patients 1, 2 and 3 showed different brain anomalies on MRI including hypoplastic olfactory bulbs in patient 3. is stronglyCPLX3 
expressed in the brain and also. Semaphorins are involved in axon guidance during neuronal development and particularly inSEMA7A 
olfactory bulbs, hippocampus, pontine nucleus and thalamocortical axon ( ; ).Maruyama and others 2008 Miyazaki and others 1999 
is strongly expressed in the heart and loss of function of can be associated with sinus nodal dysfunction such as QTHCN4 HCN4 
prolongation and polymorphic ventricular tachycardia which may lead to sudden unexpected death ( ). Therefore,Ueda and others 2004 
cardiac follow-up may be useful in 15q24 deleted patients. ECG had been performed in all 4 patients and was normal.
Array-CGH allowed in these 4 cases presenting with 15q24 microdeletion to compare their clinical features with previously reported
cases, although it is still difficult to delineate specific diagnostic criteria for this rare microdeletion syndrome. We also suggest several
candidate genes involvement in the neurological, genital and ophthalmological aspects of the phenotype.
Ackowledgements:
The authors gratefully thank the parents for their cooperation.
Footnotes:
Am J Med Genet A . Author manuscript
Page /4 6
Electronic database
UCSC Genome Browser on Human March 2006 Assembly - hg18: .http://genome.ucsc.edu/cgi-bin/hgGateway?org=human 
EMBL-EBI microarray database: http://www.ebi.ac.uk/microarray-as/atlas/
References:
  Cushman LJ , Torres-Martinez W , Cherry AM , Manning MA , Abdul-Rahman O , Anderson CE , Punnett HH , Thurston VC , Sweeney D , Vance GH . 2005 ; A report of
    three patients with an interstitial deletion of chromosome 15q24 . Am J Med Genet Part A . 137A : 65 - 71
  Formiga LD , Poenaru L , Couronne F , Flori E , Eibel JL , Deminatti MM , Savary JB , Lai JL , Gilgenkrantz S , Pierson M . 1988 ; Interstitial deletion of chromosome 15: two
    cases . Hum Genet . 80 : 401 - 404
      Hassa PO , Hottiger MO . 2008 ; The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases . Front Biosci . 13 : 3046 -
3082
  Klopocki E , Graul-Neumann LM , Grieben U , Tonnies H , Ropers HH , Horn D , Mundlos S , Ullmann R . 2008 ; A further case of the recurrent 15q24 microdeletion
    syndrome, detected by array CGH . Eur J Pediatr . 167 : 903 - 908
     Maruyama T , Matsuura M , Suzuki K , Yamamoto N . 2008 ; Cooperative activity of multiple upper layer proteins for thalamocortical axon growth . Dev Neurobiol . 68 : 317 
 - 331
  Masurel-Paulet A , Callier P , Thauvin-Robinet C , Chouchane M , Mejean N , Marle N , Mosca AL , Salem DB , Giroud M , Guibaud L . 2009 ; Multiple cysts of the corpus
    callosum and psychomotor delay in a patient with a 3.1 Mb 15q24.1q24.2 interstitial deletion identified by array-CGH . Am J Med Genet Part A . 149A : 1504 - 1510
  Miyazaki N , Furuyama T , Sakai T , Fujioka S , Mori T , Ohoka Y , Takeda N , Kubo T , Inagaki S . 1999 ; Developmental localization of semaphorin H messenger RNA
    acting as a collapsing factor on sensory axons in the mouse brain . Neuroscience . 93 : 401 - 408
  Ohkura T , Taniguchi S , Yamada K , Nishio N , Okamura T , Yoshida A , Kamijou K , Fukata S , Kuma K , Inoue Y . 2004 ; Detection of the novel autoantibody (anti-UACA
    antibody) in patients with Graves  disease ’ . Biochem Biophys Res Commun . 321 : 432 - 440
  Sharp AJ , Selzer RR , Veltman JA , Gimelli S , Gimelli G , Striano P , Coppola A , Regan R , Price SM , Knoers NV . 2007 ; Characterization of a recurrent 15q24
    microdeletion syndrome . Hum Mol Genet . 16 : 567 - 572
  Ueda K , Nakamura K , Hayashi T , Inagaki N , Takahashi M , Arimura T , Morita H , Higashiuesato Y , Hirano Y , Yasunami M . 2004 ; Functional characterization of a
    trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia . J Biol Chem . 279 : 27194 - 27198
      Van Esch H , Backx L , Pijkels E , Fryns JP . 2009 ; Congenital diaphragmatic hernia is part of the new 15q24 microdeletion syndrome . Eur J Med Genet . 52 : 153 - 156
Figure 1
Facial characteristics of the 4 patients. A: Patient 1. B: Patient 2. C: Patient 3. D: Patient 4. Note high and large forehead on patients 1, 2 and
4.
Figure 2
Schematic representation of 15q24 rearrangements published cases characterized by array-CGH with their respective breakpoints and
recurrent breakpoints BP1, BP2 and BP3 ( ). Our four cases are also represented and segmental duplications featured.Sharp and others 2007 
Recurrent breakpoint 4 (BP4) is also represented ( ). Three of our patients  deletions have BP4 as proximalMasurel-Paulet and others 2009 ’
breakpoint.
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Table 1
Phenotypic comparison between cases from ( ; ; ; ; ) and our 4Cushman and others 2005 Klopocki and others 2008 Masurel-Paulet and others 2009 Sharp and others 2007 Van Esch and others 2009 











( ) 3 casesCushman and others 2005 
( ) 4 casesSharp and others 2007 
( ) 1 caseKlopocki and others 2008 
( ) 1 caseVan Esch and others 2009 
( ) 1 caseMasurel-Paulet and others 2009 






available from ( ), ( ), (Klopocki and others 2008 Sharp and others 2007 Van Esch and others

















Sex, age at diagnosis M, 2 years M, 3 years M, 7 years F, 5 years 9 M, 1 F
13 months to 33 years
Facial characteristics large and high forehead
hypoplastic nasal bridge


















broad medial eyebrows (6/7)
hypertelorism (6/7)
epicanthal folds (4/8)
down-slanting palpebral fissures (6/7)
long and smooth philtrum (7/7)
full lower lip (5/6)
broad nasal base (3/5)
micrognathia (3/8)











Limb abnormalities bilateral single palmar creases
bilateral II III toe syndactyly–







other fingers anomalies (6/8)
Musculo-skeletal
abnormalities
no joint laxity no no joint laxity (4/8)
scoliosis (2/7)




hypospadias no no hypospadias, micropenis and/or small scrotum (8/9)
Developmental delay head control at 19 months
sitting at 2 years
walking at 29 months sitting at 15
months
walking at 3 years






first words at 3
years
mild to moderate mental retardation (10/10)
Microcephaly no no no no 3/10
Neurological cerebral atrophy thick corpus callosum hypoplastic no wide basal cisterna (1/5)
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findings enlarged ventricles olfactory bulbs dysplastic corpus callosum hypoplasia of the adenohypohysis and ectopic neurohypophysis
(1/5)
cysts in the corpus callosum (1/5)
Cardiovascular
abnormalities
ventricular septal defect no Fallot tetralogy no pulmonary stenosis (1/4)
Recurrent infections no no ENT ENT (3/4)
Deafness/hearing
loss




Skin dry normal dry normal
Other left inguinal hernia
imperforate anus
inguinal hernia (3/9)
growth hormone deficiency (2/3)
delayed puberty (2/2)
Table 2
Genes potentially involved in the 15q24 phenotype.
Gene Expression Function Localization Animal model
(transcriptional co-repressor Sin3A)SIN3A Testis Transcriptional regulatory protein, histone deacetylase interacting 15q24.2 No known KO
(outer dense fiber of sperm tails 3-like 1)ODF3L1 Testis Transport of keratins to microtubule-containing structures such as the manchette and
axoneme during mammalian spermiogenesis
15q24.2 No known KO




Localizes to the mitochondrial inner membrane and catalyzes the conversion of
cholesterol to pregnenolone
15q24.1 No known KO
(coiled-coil domain containing 33)CCDC33 Testis C2 calcium-dependent membrane targeting, down-regulated in cryptorchidism 15q24.1 No known KO
(stimulated by retinoic acid gene 6STRA6 
homolog)
Eye Receptor for retinol/retinol binding protein complexes. Removes the retinol from the
complex and transports it across the cell membrane
15q24.1 No known KO
Defects in this gene cause syndromic
microphthalmia type 9 (MCOPS9).
(uveal autoantigen with coiled-coil domainsUACA 
and ankyrin repeats)
Eye Recruits and transports the apoptosome complex during stress-induced apoptosis 15q23 No known KO
(poly (ADP-ribose) polymerase family,PARP6 
member 6)
Testis, eye NAD  ADP-ribosyltransferase activity+ 15q23 No known KO
(complexin 3)CPLX3 Brain, eye Positive regulator of neurotransmitter release in mouse hippocampal neurons, syntaxin
binding
15q24.1 No known KO
(semaphorin 7A)SEMA7A Brain Mediate neuronal functions 15q24.1 No known KO
Defects in this gene can result in loss of
bone mineral density
(hyperpolarization activated cyclicHCN4 
nucleotide-gated potassium channel 4)
Heart Necessary for the cardiac pacemaking process 15q24.1 No known KO
Mutations in this gene have been linked to
sick sinus syndrome 2
